Home › Products › Oncology › Ciclib 100mg Capsule
Ciclib 100mg Capsule
Salt Composition: PALBOCICLIB
- Manufacturer: SHILPA MEDICARE LTD
- Pack Size: 21 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 100MG
- Prescription Required
- Storage: Keep Ciclib 100 mg out of sight and reach of children. Store at 20°C to 25°C.
₹2579.00₹5500.00
Inclusive of all taxes
Product Introduction
Ciclib 100mg is a targeted anticancer therapy containing the active constituent palbociclib. It belongs to the class of medicines known as cyclin-dependent kinase inhibitors, which work by blocking certain enzymes that promote the growth of cancer cells. This medicine is primarily used in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, a condition where cancer has spread to other parts of the body. The Ciclib 100mg composition includes palbociclib as the main active ingredient, which helps slow or stop cancer cell proliferation. It is generally prescribed in combination with other hormonal or anticancer therapies to enhance effectiveness. The Ciclib 100mg dosage for breast cancer is determined by your oncologist based on your medical condition, response to treatment, and overall health. It is crucial to follow the prescribed schedule strictly to achieve optimal results. Ciclib 100mg is available through licensed pharmacies in India following your doctor's prescription. Always obtain from verified sources to ensure authenticity and quality. The Ciclib 100mg manufacturer ensures the medicine is produced under strict pharmaceutical standards to maintain safety and efficacy. Alternative brands containing the same active ingredient palbociclib are also available in India under different trade names. Before commencing treatment, patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer should discuss with their oncologist regarding possible side effects, dosage adjustments, and combination therapies to ensure safe and effective use.
Uses
Ciclib 100mg capsule uses are Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Ciclib 100 mg works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take Ciclib 100 mg exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Ciclib 100mg side effects are Serious Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing
Expert Tips
Avoid consuming grapefruit, its juices, and any products containing St. John’s wort during Ciclib 100 mg treatment. Use effective birth control during treatment and for at least: 3 weeks after the final dose (for females) 14 weeks after the final dose (for males) This medication may reduce fertility — discuss any concerns with your doctor before or during treatment. Your doctor may advise regular blood tests to monitor if Ciclib 100 mg affects your blood cell count.
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Ciclib 100 mg during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor It is not unknown whether Ciclib 100 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is not recommended to take Ciclib 100 mg while breastfeeding as it is not known whether it passes into the breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.